Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New insights on how FMDV replicates
The team are now looking at how mutations in polyproteins could be used for producing attenuated vaccines.
Tiny protein could be the key to better vaccines  

Fresh insights on the replication processes of foot-and-mouth disease virus (FMDV) could pave the way for more effective vaccines, scientists say.

New findings published in PLOS Pathogens describe a tiny protein called 3B3, which is known to play a major role in the replication of FMDV. However, it also helps to increase the efficiency with which it can pack information into the genome, according to the Pirbright Institute and the University of Leeds.

FMD has a small amount of genetic material, so it has found ways to multiply its functions. During replication, the virus creates a string of proteins called polyproteins which are then cut up into their individual proteins. The research team discovered that 3B3 is key to directing the processing of the P3 polyprotein into its constituent parts.

Such methods are also used by other members of the picornavirus family, such as poliovirus, as well as non-picornaviruses.

Scientists say that systems such as these could be exploited to develop attenuated vaccines. The team are now looking at how mutations in polyproteins could be used for producing such vaccines.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."